John Dobak - 01 Jun 2021 Form 4 Insider Report for DermTech, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Jun 2021
Net transactions value
-$500,643
Form type
4
Filing time
03 Jun 2021, 20:19:10 UTC
Next filing
10 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale $119,443 -2,970 -0.61% $40.22* 487,146 01 Jun 2021 Direct F1, F2, F3
transaction DMTK Common Stock Sale $381,200 -9,530 -2% $40.00* 477,616 02 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $40.00 to $40.55, inclusive. The reported price reflects the weighted-average sale price.
F3 The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.